Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Mannkind prices IPO

MNKD raised $87.5 million in an IPO through the sale of 6.3

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE